PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-10.89%
Negative revenue growth while ADI stands at 4.43%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-14.65%
Negative gross profit growth while ADI is at 19.52%. Joel Greenblatt would examine cost competitiveness or demand decline.
-17.85%
Negative EBIT growth while ADI is at 6.25%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-18.75%
Negative operating income growth while ADI is at 6.25%. Joel Greenblatt would press for urgent turnaround measures.
-14.51%
Negative net income growth while ADI stands at 25.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-13.94%
Negative EPS growth while ADI is at 26.21%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-13.77%
Negative diluted EPS growth while ADI is at 26.39%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.77%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.76%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
7.68%
Maintaining or increasing dividends while ADI cut them. John Neff might see a strong edge in shareholder returns.
-26.17%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-45.60%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
92.58%
10Y revenue/share CAGR at 50-75% of ADI's 176.88%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
35.39%
5Y revenue/share CAGR at 50-75% of ADI's 51.84%. Martin Whitman would worry about a lagging mid-term growth trajectory.
43.56%
3Y revenue/share CAGR at 50-75% of ADI's 62.13%. Martin Whitman would question if the firm lags behind competitor innovations.
131.20%
10Y OCF/share CAGR at 50-75% of ADI's 188.48%. Martin Whitman might fear a structural deficiency in operational efficiency.
15.09%
5Y OCF/share CAGR at 50-75% of ADI's 29.22%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
19.89%
3Y OCF/share CAGR at 75-90% of ADI's 25.86%. Bill Ackman would press for improvements in margin or overhead to catch up.
812.98%
Net income/share CAGR above 1.5x ADI's 209.56% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
520.08%
5Y net income/share CAGR above 1.5x ADI's 94.05%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
88.83%
3Y net income/share CAGR 50-75% of ADI's 142.90%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
63.37%
Below 50% of ADI's 418.68%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
53.31%
Below 50% of ADI's 158.58%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
68.54%
3Y equity/share CAGR at 50-75% of ADI's 124.37%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
487.06%
10Y dividend/share CAGR above 1.5x ADI's 153.11%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
99.82%
5Y dividend/share CAGR 1.25-1.5x ADI's 68.57%. Bruce Berkowitz verifies that high dividend hikes remain sustainable, not a sign of over-distribution.
37.51%
3Y dividend/share CAGR similar to ADI's 40.48%. Walter Schloss finds parallel short-term dividend strategies for both companies.
-7.11%
Firm’s AR is declining while ADI shows 3.32%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
14.68%
Inventory growth well above ADI's 16.33%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
4.41%
Positive asset growth while ADI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
1.26%
BV/share growth above 1.5x ADI's 0.46%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
14.39%
Debt growth far above ADI's 4.73%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
0.70%
We increase R&D while ADI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-0.46%
We cut SG&A while ADI invests at 3.66%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.